- Raised $2M funding round, Sep 2018
About
CTG Pharma's solution enables chimeric antigen receptor (CAR) T therapy for HER2-positive solid tumors while mitigating toxicity and on-target off-tumor reactions. CTG Pharma's solutions include a library of 65,000 promoters that enable safer CAR T for the treatment of solid tumors, applicable to any CAR and suitable for a variety of tumor micro-environment conditions. CTG Pharma aims to create a broadly applicable platform to enhance the safety and efficacy of a variety of human CAR T therapies requiring regulation of CAR expression. The platform is composed of a rationally designed library of 65,000 different switches, for minimal immune response in healthy tissues and maximum expression of the CAR specifically in the tumor surroundings. It is a highly sensitive system that integrates unique signals from the solid tumor microenvironment for the regulation of CAR expression. The company's first line of products is HER2-positive cancers.
Funding history · 1 round · $2.0M total
Q&A
- What is CTG Pharma's primary focus?
- CTG Pharma focuses on enabling therapeutic application of Chimeric Antigen Receptor (CAR) T cells in solid tumors, specifically for HER2-positive cancers, while mitigating toxicity.
- When was CTG Pharma founded?
- CTG Pharma was founded in January 2016.
- What is the current status of CTG Pharma?
- CTG Pharma is currently inactive, having ceased operations in September 2022.
- How much funding has CTG Pharma raised in total?
- CTG Pharma has raised a total of $2,000,000.
- Which investor participated in CTG Pharma's funding round?
- aMoon Fund participated in CTG Pharma's funding round in September 2018.
- What is CTG Pharma's employee count?
- CTG Pharma has an employee count in the 1-10 range.
- Where is CTG Pharma headquartered?
- CTG Pharma is headquartered in Rehovot, Center District, Israel.
- Who are the co-founders of CTG Pharma?
- The co-founders of CTG Pharma are Yoav Ben-Yaacov, Zelig Eshar, and Salomon Stemmer.
Team · 3
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/42122350 |
Identifiers & details
| Founded | 2016-1 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Sep 2022 ceased to operate |